Anti-obesity drugs Wegovy and Mounjaro soon to be reimbursed

France is set to reimburse anti-obesity drugs Wegovy and Mounjaro, marking a major breakthrough in treating this chronic disease.

Published 10sem2 sources✓ ConfirmedNotable

≈ 22sSpeed

The fact

This decision comes as obesity rises in France and access to current treatments remains unequal.

Reimbursement should improve access to these therapies for eligible patients under medical prescription.

2 sources — click a link to read an article on the topic:

Explore this topic

May 27Anti-obesity drugs Wegovy and Mounjaro soon to be reimbursedthis article

Auto-synthesis from 2 media sources · identified on May 27, 2026